Progression of Presumed Pentosan Polysulfate Sodium Maculopathy After Drug Cessation
This case report discusses presumed progression of maculopathy secondary to pentosan polysulfate sodium prescribed for daily use over a period of 4 years in a patient with a history of interstitial cystitis.
Authors
- Kimberly E. Stepien (ORCID: https://orcid.org/0000-0002-4498-6495)
- Hyun Sue Kim (ORCID: https://orcid.org/0000-0002-4727-6499)
- Elaine Botros
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1001/jamaophthalmol.2025.3642
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00